|
|
The design of brain-targeted Ag2S quantum dot and its property of crossing the in vitro blood brain barrier |
XU Yi1, 2, YAN Meiling2, MA Jifei3, ZHAO Fangfei2, SUN Yanhong2, WANG Lihua2, GAO Jimin1 |
1.School of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou 325035, China; 2.CAS Key Laboratory of Interfacial Physics and Technology, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China |
|
Cite this article: |
XU Yi,YAN Meiling,MA Jifei, et al. The design of brain-targeted Ag2S quantum dot and its property of crossing the in vitro blood brain barrier[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2020, 50(3): 206-211.
|
|
Abstract Objective: To design the brain targeted Ag2S and Ag2S-PEG quantum dots and evaluate the property of the modified quantum dots in crossing the in vitro blood-brain barrier. Methods: Ag2S was conjugated with Angiopep-2 (Ag2S-ANG) and Ag2S-PEG was conjugated with Angiopep-2 (Ag2S-PEG-ANG) through the condensation reaction of amino and carboxyl groups mediated by EDC and NHS. The structure and size of Ag2S, Ag2S-ANG, Ag2S-PEG, Ag2S-PEG-ANG were characterized by agarose electrophoresis, dynamic light scattering transmission, electron microscope (TEM). The property of four kinds of quantum dots across the blood-brain barrier was evaluated in vitro by using the in vitro blood-brain barrier model. The cytotoxicity of four kinds of materials on U87 MG and bEnd.3 cells was observed. Results: Ag2S-ANG and Ag2S-PEG-ANG had a shorter migration distance compared with Ag2S and Ag2S-PEG in the agarose gel electrophoresis. The hydrate particle size of Ag2S-ANG and Ag2S-PEG-ANG was respectively increased compared with Ag2S and Ag2S-PEG. And their Zeta potential exhibited electropositive reinforcement. From the TEM results, we founded that the partical size of Ag2S-ANG and Ag2S-PEG-ANG was bigger than Ag2S and Ag2S-PEG (P<0.05). Ag2S, Ag2S-ANG, Ag2S-PEG, Ag2S-PEG-ANG QDs had no obvious cytotoxicity when the concentration was lower than 100 μg/mL. In vitro blood-brain barrier cell model, Ag2S-ANG, Ag2S-PEG and Ag2S-PEG-ANG quantum dots could cross the bEnd.3 cells in the upper layer, especially when the uptake of Ag2S-ANG was 6 times that of Ag2S by U87 MG cells in the lower layer (P<0.01). Conclusion: Brain targeted Ag2S-ANG and Ag2S-PEG-ANG are synthesized successfully. Ag2S-ANG QDs exhibit excellent ability to cross the blood-brain barrier system in vitro and target glioma cells, which lays the foundations for further study of in vivo brain targeting imaging.
|
|
|
|
|
|
[1] 张叶俊, 王强斌. 近红外Ag2S量子点的研究进展[J]. 中国材料进展, 2016, 35(1): 17-27.
[2] SMITH A M, MANCINI M C, NIE S. Bioimaging: second window for in vivo imaging[J]. Nat Nanotechnol, 2009, 4(11): 710-711.
[3] ANTARIS A L, CHEN H, CHENG K, et al. A small-molecule dye for NIR-II imaging[J]. Nat Mater, 2016, 15(2): 235-242.
[4] YI W, ZHOU H, LI A, et al. A NIR-II fluorescent probe for articular cartilage degeneration imaging and osteoarthritis detection[J]. Biomater Sci, 2019, 7(3): 1043-1051.
[5] DU Y, XU B, FU T, et al. Near-infrared photoluminescent Ag2S quantum dots from a single source precursor[J]. J Am Chem Soc, 2010, 132(5): 1470-1471.
[6] ZHANG Y, ZHANG Y, HONG G, et al. Biodistribution, pharmacokinetics and toxicology of Ag2S near-infrared quantum dots in mice[J]. Biomaterials, 2013, 34(14): 3639-3646.
[7] ZHANG Y, HONG G, ZHANG Y, et al. Ag2S quantum dot: a bright and biocompatible fluorescent nanoprobe in the second near-infrared window[J]. ACS Nano, 2012, 6(5): 3695-3702.
[8] LI C, ZHANG Y, WANG M, et al. In vivo real-time visualization of tissue blood flow and angiogenesis using Ag2S quantum dots in the NIR-II window[J]. Biomaterials, 2014, 35(1): 393-400.
[9] 徐毅, 赵彦, 张叶俊, 等. Angiopep-2修饰的Ag2S量子点用于近红外二区脑胶质瘤成像[J]. 化学学报, 2018, 76(5): 393-399.
[10] RAULT I, FREI V, HERBAGE D, et al. Evaluation of different chemical methods for cros-linking collagen gel, films and sponges[J]. J Mater Sci Mater Med, 1996, 7(4): 215-221.
[11] HARDZEI M, ARTEMYEV M, MOLINARI M, et al. Comparative efficiency of energy transfer from CdSe-ZnS quantum dots or nanorods to organic dye molecules[J]. Chemphyschem, 2012, 13(1): 330-335.
[12] CLAPP A R, MEDINTZ I L, FISHER B R, et al. Can luminescent quantum dots be efficient energy acceptors with organic dye donors?[J]. J Am Chem Soc, 2005, 127(4): 1242-1250.
[13] ABBOTT N J, PATABENDIGE A A, DOLMAN D E, et al. Structure and function of the blood-brain barrier[J]. Neurobiol Dis, 2010, 37(1): 13-25.
[14] TAJES M, RAMOS-FERNáNDEZ E, WENG-JIANG X,
et al. The blood-brain barrier: structure, function and therapeutic approaches to cross it[J]. Mol Membr Biol, 2014, 31(5): 152-167.
[15] ABBOTT N J. Prediction of blood-brain barrier permeation in drug discovery from in vivo, in vitro and in silico models[J]. Drug Discov Today Technol, 2004, 1(4): 407-416.
[16] CHEN Y, LIU L. Modern methods for delivery of drugs across the blood-brain barrier[J]. Adv Drug Deliv Rev, 2012, 64(7): 640-665.
[17] PARDRIDGE W M. Drug and gene targeting to the brain with molecular Trojan horses[J]. Nat Rev Drug Discov, 2002, 1(2): 131-139.
[18] JAIN S, MISHRA V, SINGH P, et al. RGD-anchored magnetic liposomes for monocytes/neutrophils-mediated brain targeting[J]. Int J Pharm, 2003, 261(1-2): 43-55.
[19] GE Z, PEI H, WANG L, et al. Electrochemical single nucleotide polymorphisms genotyping on surface immobilized three-dimensional branched DNA nanostructure[J]. Sci China Chem, 2011, 54(8): 1273-1276.
[20] PEI H, LIANG L, YAO G, et al. Reconfigurable three-dimensional DNA nanostructures for the construction of intracellular logic sensors[J]. Angew Chem Int Ed Engl, 2012, 51(36): 9020-9024.
[21] YANG F, ZUO X, LI Z, et al. A bubble-mediated intelligent microscale electrochemical device for single-step quantitative bioassays[J]. Adv Mater, 2014, 26(27): 4671-4676.
[22] 叶德楷, 左小磊, 樊春海. 基于DNA纳米结构的传感界面调控及生物检测应用[J].化学进展,2017,29(1): 36-46.
[23] YAO G, LI J, CHAO J, et al. Gold-nanoparticle-mediated jigsaw-puzzle-like assembly of supersized plasmonic DNA origami[J]. Angew Chem Int Ed Engl, 2015, 54(10): 2966-2969.
[24] CHEN P, PAN D, FAN C, et al. Gold nanoparticles for high-throughput genotyping of long-range haplotypes[J]. Nat Nanotechnol, 2011, 6(10): 639-644.
[25] CHERTOK B, MOFFAT B A, DAVID A E, et al. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors[J]. Biomaterials, 2008, 29(4): 487-496.
[26] LI D, YANG K, LI J S, et al. Antitumor efficacy of a novel CLA-PTX microemulsion against brain tumors: in vitro and in vivo findings[J]. Int J Nanomedicine, 2012, 7: 6105-6114.
[27] LIU H L, HUA M Y, YANG H W, et al. Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain[J]. Proc Natl Acad Sci U S A, 2010, 107(34): 15205-15210.
[28] QIAN X, PENG X H, ANSARI D O, et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags[J]. Nat Biotechnol, 2008, 26(1): 83-90.
[29] GAO X, CUI Y, LEVENSON R M, et al. In vivo cancer targeting and imaging with semiconductor quantum dots[J]. Nat Biotechnol, 2004, 22(8): 969-976. |
|
|
|